Successful Incidences of Controlling Multidrug-Resistant, Extensively Drug-Resistant, and Nosocomial Infection Acinetobacter baumannii Using Antibiotic Stewardship, Infection Control Programs, and Environmental Cleaning at a Chinese University Hospital

References

• Chen CH, Lin LC, Chang YJ, Chen YM, Chang CY, Huang CC. Infection control programs and antibiotic control programs to limit transmission of multi-drug resistant acinetobacter baumannii infections: evolution of old problems and new challenges for institutes. Int J Environ Res Public Health. 2015;12(8):8871–8882. doi:10.3390/ijerph12080887126264006
   PubMed Web of Science ®Google Scholar
• Gaynes R, Edwards JR; National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41(6):848–854. doi:10.1086/43280316107985
   PubMed Web of Science ®Google Scholar
• Nhu NTK, Lan NPH, Campbell JI, et al. Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam. J Med Microbiol. 2014;63(Pt 10):1386–1394. doi:10.1099/jmm.0.076646-025038137
   PubMed Web of Science ®Google Scholar
• Qureshi ZA, Hittle LE, O’Hara JA, et al. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance. Clin Infect Dis. 2015;60(9):1295–1303. doi:10.1093/cid/civ04825632010
   PubMed Web of Science ®Google Scholar
• Vázquez-López R, Solano-Gálvez SG, Juárez Vignon-Whaley JJ, et al. Acinetobacter baumannii resistance: a real challenge for clinicians. Antibiotics (Basel). 2020;9(4):205. doi:10.3390/antibiotics9040205
   Web of Science ®Google Scholar
• Karaiskos I, Giamarellou H. Multidrug-resistant and extensively drug-resistant gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother. 2014;15:1351–1370. doi:10.1517/14656566.2014.91417224766095
   PubMed Web of Science ®Google Scholar
• Apisarnthanarak A, Khawcharoenporn T, Mundy LM. Practices to prevent multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus in Thailand: a national survey. Am J Infect Control. 2013;41:416–421. doi:10.1016/j.ajic.2012.05.01123098775
   PubMed Web of Science ®Google Scholar
• Cho OH, Bak MH, Baek EH, Park KH, Kim S, Bae IG. Successful control of carbapenem-resistant Acinetobacter baumannii in a Korean university hospital: a 6-year perspective. Am J Infect Control. 2014;42(9):976–979. doi:10.1016/j.ajic.2014.05.02725179329
   PubMed Web of Science ®Google Scholar
• Rodríguez-Baño J, García L, Ramírez E, et al. Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive “bundle” approach. Am J Infect Control. 2009;37(9):715–722. doi:10.1016/j.ajic.2009.01.00819457584
   PubMed Web of Science ®Google Scholar
• Cheon S, Kim MJ, Yun SJ, Moon JY, Kim YS. Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control. Korean J Intern Med. 2016;31(2):367–374. doi:10.3904/kjim.2015.17826874513
   PubMed Web of Science ®Google Scholar
• Teerawattanapong N, Kengkla K, Dilokthornsakul P, Saokaew S, Apisarnthanarak A, Chaiyakunapruk N. Prevention and control of multidrug-resistant gram-negative bacteria in adult intensive care units: a systematic review and network meta-analysis. Clin Infect Dis. 2017;64(suppl_2):S51–S60. doi:10.1093/cid/cix11228475791
   PubMed Web of Science ®Google Scholar
• Moodley P, Whitelaw A. The pros, cons, and unknowns of search and destroy for carbapenem-resistant enterobacteriaceae. Curr Infect Dis Rep. 2015;17(6):483. doi:10.1007/s11908-015-0483-825916995
   PubMed Web of Science ®Google Scholar
• He S, Li Z, Yang Q, Quan M, Zhao L, Hong Z. Resistance trends among 1294 nosocomial acinetobacter baumannii strains from a tertiary general Hospital in China, 2014–2017. Clin Lab. 2020;66(3). doi:10.7754/Clin.Lab.2019.190629
   Web of Science ®Google Scholar
• Romanin P, Palermo RL, Cavalini JF, et al. Multidrug- and extensively drug-resistant acinetobacter baumannii in a tertiary hospital from brazil: the importance of carbapenemase encoding genes and epidemic clonal complexes in a 10-year study. Microb Drug Resist. 2019;25(9):1365–1373. doi:10.1089/mdr.2019.000231361565
   PubMed Web of Science ®Google Scholar
• Molter G, Seifert H, Mandraka F, et al. Outbreak of carbapenem resistant Acinetobacter baumannii in the intensive care unit: a multi-level strategic management approach. J Hosp Infect. 2016;92(2):194–198. doi:10.1016/j.jhin.2015.11.00726778130
   PubMed Web of Science ®Google Scholar
• Ayraud-Thevenot S, Huart C, Mimoz O, et al. Control of multi-drug-resistant Acinetobacter baumannii outbreaks in an intensive care unit: feasibility and economic impact of rapid unit closure. J Hosp Infect. 2012;82(4):290–292. doi:10.1016/j.jhin.2012.08.01623102815
   PubMed Web of Science ®Google Scholar
• Wilson AP, Livermore DM, Otter JA, et al. Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party. J Hosp Infect. 2016;92(Suppl 1):S1–S44. doi:10.1016/j.jhin.2015.08.00726598314
   PubMed Web of Science ®Google Scholar
• Casini B, Righi A, De Feo N, et al. Improving cleaning and disinfection of high-touch surfaces in intensive care during carbapenem-resistant acinetobacter baumannii endemo-epidemic situations. Int J Environ Res Public Health. 2018;15(10):2305. doi:10.3390/ijerph15102305
   Web of Science ®Google Scholar
• Li QF, Xu H, Ni XP, et al. Impact of relocation and environmental cleaning on reducing the incidence of healthcare-associated infection in NICU. World J Pediatr. 2017;13(3):217–221. doi:10.1007/s12519-017-0001-128101771
   PubMed Web of Science ®Google Scholar
• Anudit C, Kooltheat N, Potup P, Pankla Sranujit R, Usuwanthim K. Nosocomial infection of multidrug-resistant Acinetobacter baumannii in Thailand. Am J Infect Control. 2016;44(10):1161–1163. doi:10.1016/j.ajic.2016.03.06827375062
   PubMed Web of Science ®Google Scholar
• Liu L, Liu B, Li Y, Zhang W. Successful control of resistance in Pseudomonas aeruginosa using antibiotic stewardship and infection control programs at a Chinese university hospital: a 6-year prospective study. Infect Drug Resist. 2018;11:637–646. doi:10.2147/IDR.S16385329750044
   PubMed Web of Science ®Google Scholar
• Leclercq R, Cantón R, Brown DF, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2013;19(2):141–160. doi:10.1111/j.1469-0691.2011.03703.x22117544
   PubMed Web of Science ®Google Scholar
• Chang YY, Chen HP, Lin CW, et al. Implementation and outcomes of an antimicrobial stewardship program: effectiveness of education. J Chin Med Assoc. 2017;80(6):353–359. doi:10.1016/j.jcma.2016.09.01228411959
   PubMed Web of Science ®Google Scholar
• Goossens H, Ferech M, Vander Stichele R, Elseviers M; Group EP. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579–587. doi:10.1016/S0140-6736(05)70799-615708101
   PubMed Web of Science ®Google Scholar
• Cohen AL, Calfee D, Fridkin SK, et al. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC position paper. Infect Control Hosp Epidemiol. 2008;29:901–913. doi:10.1086/59174118808340
   PubMed Web of Science ®Google Scholar
• Borg MA. National cultural dimensions as drivers of inappropriate ambulatory care consumption of antibiotics in Europe and their relevance to awareness campaigns. J Antimicrob Chemother. 2012;67:763–767. doi:10.1093/jac/dkr54122200725
   PubMed Web of Science ®Google Scholar
• Froment P, Marchandin H, Vande Perre P, Lamy B. Automated versus manual sample inoculations in routine clinical microbiology: a performance evaluation of the fully automated InoqulA instrument. J Clin Microbiol. 2014;52(3):796–802. doi:10.1128/JCM.02341-1324353001
   PubMed Web of Science ®Google Scholar
• Degli Atti MC, Bernaschi P, Carletti M, et al. An outbreak of extremely drug resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy. BMC Infect Dis. 2014;14:494. doi:10.1186/1471-2334-14-49425209325
   PubMed Web of Science ®Google Scholar
• Zhao SY, Jiang DY, Xu PC, et al. An investigation of drug-resistant acinetobacter baumannii infections in a comprehensive hospital of East China. Ann Clin Microbiol Antimicrob. 2015;14(7). doi:10.1186/s12941-015-0066-4
   Web of Science ®Google Scholar
• Yuan WL, Shen YJ, Deng DY. Sex bias of Acinetobacter baumannii nosocomial infection. Am J Infect Control. 2018;46(8):957–958. doi:10.1016/j.ajic.2018.04.23129910034
   PubMed Web of Science ®Google Scholar
• Lim CLL, Chua AQ, Teo JQM, Cai Y, Lee W, Kwa AL. Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review and meta-analysis. Int J Infect Dis. 2018;76:48–57. doi:10.1016/j.ijid.2018.05.01729870795
   PubMed Web of Science ®Google Scholar
• Wang CH, Li JF, Huang LY, et al. Outbreak of imipenem-resistant Acinetobacter baumannii in different wards at a regional hospital related to untrained bedside caregivers. Am J Infect Control. 2017;45(10):1086–1090. doi:10.1016/j.ajic.2017.04.01628549878
   PubMed Web of Science ®Google Scholar
• MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18(4):638–656. doi:10.1128/CMR.18.4.638-656.200516223951
   PubMed Web of Science ®Google Scholar
• Ni W, Han Y, Zhao J, et al. Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis. Int J Antimicrob Agents. 2016;47(2):107–116. doi:10.1016/j.ijantimicag.2015.11.01126742726
   PubMed Web of Science ®Google Scholar
• Warde E, Davies E, Ward A. Control of a multidrug-resistant Acinetobacter baumannii outbreak. Br J Nurs. 2019;28(4):242–248. doi:10.12968/bjon.2019.28.4.24230811227
   PubMedGoogle Scholar
• Muñoz-Price LS, Carling P, Clearly T, et al. Control of a two-decade endemic situation with carbapenem-resistant Acinetobacter baumannii: electronic dissemination of a bundle of interventions. Am J Infect Control. 2014;42:466–471. doi:https://doi.org/10.1016/j.ajic.2013.12.02424773784
   PubMed Web of Science ®Google Scholar
• Stalsby Lundborg C, Tamhankar AJ. Understanding and changing human behaviour–antibiotic mainstreaming as an approach to facilitate modification of provider and consumer behaviour. Ups J Med Sci. 2014;119:125–133. doi:10.3109/03009734.2014.90566424735112
   PubMed Web of Science ®Google Scholar
• Sahoo KC, Tamhankar AJ, Johansson E, et al. Antibiotic use, resistance development and environmental factors: a qualitative study among healthcare professionals in Orissa, India. BMC Public Health. 2010;10:629. doi:10.1186/1471-2458-10-62920964815
   PubMed Web of Science ®Google Scholar
• Hong J, Jang OJ, Bak MH, et al. Management of carbapenem-resistant Acinetobacter baumannii epidemic in an intensive care unit using multifaceted intervention strategy. Korean J Intern Med. 2018;33(5):1000–1007. doi:10.3904/kjim.2016.32329172401
   PubMed Web of Science ®Google Scholar
• Aljindan R, Bukharie H, Alomar A, Abdalhamid B. Prevalence of digestive tract colonization of carbapenem-resistant Acinetobacter baumannii in hospitals in Saudi Arabia. J Med Microbiol. 2015;64(Pt 4):400–406. doi:10.1099/jmm.0.00003325657302
   PubMed Web of Science ®Google Scholar
• Biswas D, Tiwari M, Tiwari V. Comparative mechanism based study on disinfectants against multidrug-resistant Acinetobacter baumannii. J Cell Biochem. 2018;119(12):10314–10326. doi:10.1002/jcb.2737330145822
   PubMed Web of Science ®Google Scholar
• Bianco A, Quirino A, Giordano M, et al. Control of carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit of a teaching hospital in Southern Italy. BMC Infect Dis. 2016;16(1):747. doi:10.1186/s12879-016-2036-727955639
   PubMed Web of Science ®Google Scholar
• Doi Y, Murray GL, Peleg AY. Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Semin Respir Crit Care Med. 2015;36(1):85–98. doi:10.1055/s-0034-139838825643273
   PubMed Web of Science ®Google Scholar
• Cartelle Gestal M, Zurita J, Gualpa G, Gonzalez C, Paz Y, Mino A. Early detection and control of an Acinetobacter baumannii multi-resistant outbreak in a hospital in Quito, Ecuador. J Infect Dev Ctries. 2016;10(12):1294–1298. doi:10.3855/jidc.754428036308
   PubMed Web of Science ®Google Scholar
• Carlet J, Collignon P, Goldmann D, et al. Society’s failure to protect a precious resource: antibiotics. Lancet. 2011;378(9788):369–371. doi:10.1016/S0140-6736(11)60401-721477855
   PubMed Web of Science ®Google Scholar
• Zhu X, Tong A, Wang D, Sun H, Chen L, Dong M. Antibiotic resistance patterns of Gram-negative and Gram-positive strains isolated from inpatients with nosocomial infections in a tertiary hospital in Beijing, China from 2011 to 2014. J Chemother. 2016;27:1–4.
   Google Scholar
• Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug- resistant Acinetobacter baumannii infections. Lancet Infect Dis. 2008;8:751–762. doi:10.1016/S1473-3099(08)70279-219022191
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Sifakis F, Harbarth S, et al. Surveillance for control of antimicrobial resistance. Lancet Infect Dis. 2018;18(3):e99–e106. doi:10.1016/S1473-3099(17)30485-129102325
   PubMed Web of Science ®Google Scholar
• Bassetti M, Righi E, Vena A, Graziano E, Russo A, Peghin M. Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria. Curr Opin Crit Care. 2018;24(5):385–393. doi:10.1097/MCC.000000000000053430156569
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E, Wiener-Well Y, Lesho E, et al. An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital. Crit Care. 2018;22(1):319. doi:10.1186/s13054-018-2247-y30463589
   PubMed Web of Science ®Google Scholar
• Shamsizadeh Z, Nikaeen M, Nasr Esfahani B, Mirhoseini SH, Hatamzadeh M, Hassanzadeh A. Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections. Environ Health Prev Med. 2017;22(1):44. doi:10.1186/s12199-017-0653-429165152
   PubMed Web of Science ®Google Scholar
• Cheng VCC, Wong SC, Chen JHK, et al. Control of multidrug-resistant Acinetobacter baumannii in Hong Kong: role of environmental surveillance in communal areas after a hospital outbreak. Am J Infect Control. 2018;46(1):60–66. doi:10.1016/j.ajic.2017.07.01028893447
   PubMed Web of Science ®Google Scholar
• Apisarnthanarak A, Warren DK, Fraser VJ. Creating a cohort area to limit transmission of pandrug-resistant Acinetobacter baumannii in a Thai tertiary care center. Clin Infect Dis. 2009;48:1487–1488. doi:10.1086/59851219374565
   PubMed Web of Science ®Google Scholar
• Siegel JD, Rhinehart E, Jackson M, et al.; Healthcare Infection Control Practices Advisory Committee. 2007 guidelines for isolation precautions: preventing transmission of infectious agents in healthcare settings. Am J Infect Control. 2007;35(10):6490–6497. doi:10.1016/j.ajic.2007.10.007.
   Web of Science ®Google Scholar
• Edwards J, Patel G, Wareham DW. Low concentrations of commercial alcohol hand rubs facilitate growth of and secretion of extracellular proteins by multidrug-resistant strains of Acinetobacter baumannii. J Med Microbiol. 2007;56:1595–1599. doi:10.1099/jmm.0.47442-018033825
   PubMed Web of Science ®Google Scholar
• Gajdács M. The concept of an ideal antibiotic: implications for drug design. Molecules. 2019;24(5):892. doi:10.3390/molecules24050892
   PubMed Web of Science ®Google Scholar